Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours.

Naito, Yoichi; Nishida, Toshirou; Doi, Toshihiko

Naito, Yoichi; Nishida, Toshirou; Doi, Toshihiko.

Affiliation

Naito Y; Department of General Internal Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. ynaito@east.ncc.go.jp.
Nishida T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan. ynaito@east.ncc.go.jp.
Doi T; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. ynaito@east.ncc.go.jp.

Gastric Cancer ; 26(3): 339-351, 2023 05.

Article in En | MEDLINE | ID: mdl-36913072

Subject(s)

Antineoplastic Agents; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Stomach Neoplasms; Humans; Gastrointestinal Stromal Tumors/drug therapy; Gastrointestinal Stromal Tumors/genetics; Gastrointestinal Stromal Tumors/pathology; Imatinib Mesylate/therapeutic use; Gastrointestinal Neoplasms/drug therapy; Gastrointestinal Neoplasms/genetics; Gastrointestinal Neoplasms/pathology; Stomach Neoplasms/drug therapy; Neoplasm Recurrence, Local/drug therapy; Antineoplastic Agents/therapeutic use; Antineoplastic Agents/pharmacology; Protein Kinase Inhibitors/therapeutic use; Protein Kinase Inhibitors/pharmacology

Key words

Fourth-line treatment; Gastrointestinal stromal tumours; Refractory GIST

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Gastrointestinal Stromal Tumors / Gastrointestinal Neoplasms / Antineoplastic Agents Type of study: Guideline Limits: Humans Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2023 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google